BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, February 14, 2026
Home
»
Topics
»
Regulatory
» EMA
EMA
RSS
EC grants orphan drug status for pralatrexate in Hodgkin's lymphoma
Oct. 19, 2010
European orphan drug status for NeuroSTAT in traumatic brain injury
Oct. 18, 2010
EMA approves Twynsta single pill combination for high blood pressure
Oct. 14, 2010
Tesetaxel receives EMA orphan drug status for gastric cancer
Oct. 14, 2010
Merck KGaA to appeal CHMP's opinion on cladribine tablets in MS
Oct. 11, 2010
CHMP recommends variation to terms of marketing authorization for Invega
Oct. 5, 2010
Prefilled syringes of Relistor approved in U.S., E.U. and Canada
Oct. 1, 2010
Novartis' H5N1 vaccine Aflunov for adults gets positive opinion in E.U.
Sep. 29, 2010
CHMP recommends approval of AstraZeneca's ticagrelor
Sep. 29, 2010
CHMP finds no causal relationship between GSK's Pandemrix vaccine and narcolepsy
Sep. 28, 2010
Previous
1
2
…
137
138
139
140
141
142
143
144
145
…
158
159
Next
RSS